GB0324778D0 - Method - Google Patents

Method

Info

Publication number
GB0324778D0
GB0324778D0 GB0324778A GB0324778A GB0324778D0 GB 0324778 D0 GB0324778 D0 GB 0324778D0 GB 0324778 A GB0324778 A GB 0324778A GB 0324778 A GB0324778 A GB 0324778A GB 0324778 D0 GB0324778 D0 GB 0324778D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0324778A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forinnova AS
Original Assignee
Forinnova AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forinnova AS filed Critical Forinnova AS
Priority to GB0324778A priority Critical patent/GB0324778D0/en
Publication of GB0324778D0 publication Critical patent/GB0324778D0/en
Priority to PCT/GB2004/004471 priority patent/WO2005042776A1/en
Ceased legal-status Critical Current

Links

GB0324778A 2003-10-23 2003-10-23 Method Ceased GB0324778D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0324778A GB0324778D0 (en) 2003-10-23 2003-10-23 Method
PCT/GB2004/004471 WO2005042776A1 (en) 2003-10-23 2004-10-22 Method of determining predisposition towards atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0324778A GB0324778D0 (en) 2003-10-23 2003-10-23 Method

Publications (1)

Publication Number Publication Date
GB0324778D0 true GB0324778D0 (en) 2003-11-26

Family

ID=29595705

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0324778A Ceased GB0324778D0 (en) 2003-10-23 2003-10-23 Method

Country Status (2)

Country Link
GB (1) GB0324778D0 (en)
WO (1) WO2005042776A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013109144A1 (en) * 2012-01-18 2013-07-25 Stichting Katholieke Universiteit Annexin a5 snp in atherosclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046715A1 (en) * 1996-06-03 1997-12-11 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Fc receptor polymorphism
WO1999032659A1 (en) * 1997-12-22 1999-07-01 Stiftelsen Universitetsforskning Bergen (Unifob) METHOD FOR DISEASE PROGNOSIS BASED ON Fc RECEPTOR GENOTYPING
GB9919194D0 (en) * 1999-08-14 1999-10-20 Univ Leeds Genetic marker for rheumatoid arthritis
DE10061279A1 (en) * 2000-12-08 2002-07-25 Vinzenz Hombach Assessing risk of arteriosclerosis and cardiovascular disease, by identifying allelic variants of the CD32 gene or related protein mutations
JP4216720B2 (en) * 2001-10-19 2009-01-28 サントル・オスピタリエ・レジオナル・エ・ユニヴェルシタイル・ドゥ・トゥール Methods and compositions for assessing antibody treatment response

Also Published As

Publication number Publication date
WO2005042776A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
GB0323039D0 (en) Method
EP1675596A4 (en) Method
GB0312781D0 (en) Method
GB0313569D0 (en) Method
GB0301117D0 (en) Method
GB0316553D0 (en) Method
GB0326396D0 (en) Method
GB0308852D0 (en) Method
GB0307329D0 (en) Method
GB0324465D0 (en) Method
GB0316555D0 (en) Method
GB0323703D0 (en) Method
GB0304632D0 (en) Method
EP1612264A4 (en) Organ-forming method
EP1694837A4 (en) Method
GB0324778D0 (en) Method
GB0303536D0 (en) Method
GB0316314D0 (en) Method
GB0317826D0 (en) Method
GB0301122D0 (en) Method
GB0305811D0 (en) Method
GB0307533D0 (en) Method
GB0307535D0 (en) Method
GB0300194D0 (en) Method
GB0311789D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)